1. Home
  2. Labeler Index
  3. Astrazeneca Ab
  4. 17228-7303
  5. NDC Package Code: 17228-7303-5 Metoprolol Succinate

NDC Package 17228-7303-5 Metoprolol Succinate

Tablet, Extended Release - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is an UNFINISHED DRUG part of the official NDC directory. Unfinished drugs include products like active ingredients some of which are used in bulk for further processing or compounding. The FDA requires a list of these drugs manufactured in a U.S. commercial distribution facility.

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
17228-7303-5
Package Description:
11000 TABLET, EXTENDED RELEASE in 1 DRUM
Product Code:
17228-7303
Non-Proprietary Name:
Metoprolol Succinate
Substance Name:
Metoprolol Succinate
Usage Information:
This medication is a beta-blocker used to treat chest pain (angina), heart failure, and high blood pressure. Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. This drug works by blocking the action of certain natural chemicals in your body (such as epinephrine) that affect the heart and blood vessels. This lowers heart rate, blood pressure, and strain on the heart.
11-Digit NDC Billing Format:
17228730305
Product Type:
Bulk Ingredient
Labeler Name:
Astrazeneca Ab
Dosage Form:
Tablet, Extended Release - A solid dosage form containing a drug which allows at least a reduction in dosing frequency as compared to that drug presented in conventional dosage form.
Active Ingredient(s):
  • METOPROLOL SUCCINATE 200 mg/1
    • Sample Package:
    N/A
    Marketing Category:
    DRUG FOR FURTHER PROCESSING - A drug (other than the bulk ingredient API) that is in an interim stage of manufacture, processing, preparation, or packaging, and not ready for human or animal use.
    Start Marketing Date:
    11-21-2006
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Unfinished Product:
    Yes
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 17228-7303-5?

    The NDC Packaged Code 17228-7303-5 is assigned to an UNFINISHED drug package of 11000 tablet, extended release in 1 drum of Metoprolol Succinate, a bulk ingredient labeled by Astrazeneca Ab. The product's dosage form is tablet, extended release and is administered via form.

    Is NDC 17228-7303 included in the NDC Directory?

    Yes, Metoprolol Succinate is an UNFINISHED PRODUCT with code 17228-7303 that is active and included in the NDC Directory. The product was first marketed by Astrazeneca Ab on November 21, 2006 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 17228-7303-5?

    The 11-digit format is 17228730305. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-4-1 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-4-117228-7303-55-4-217228-7303-05